{"id":725823,"date":"2023-01-25T16:03:44","date_gmt":"2023-01-25T21:03:44","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/alert-the-ma-class-action-firm-continues-investigating-the-merger-hznp-angn-tig-cnce\/"},"modified":"2023-01-25T16:03:44","modified_gmt":"2023-01-25T21:03:44","slug":"alert-the-ma-class-action-firm-continues-investigating-the-merger-hznp-angn-tig-cnce","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/alert-the-ma-class-action-firm-continues-investigating-the-merger-hznp-angn-tig-cnce\/","title":{"rendered":"ALERT: The M&amp;A Class Action Firm Continues Investigating the Merger \u2013 HZNP, ANGN, TIG, CNCE"},"content":{"rendered":"<div class=\"mw_release\">\n<p>NEW YORK, Jan.  25, 2023  (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=4V3H3k36R2EhoeSerMWjYR0b149ydEgWwB9GWfTHZe-D8KGsFotsbKYOO1QntCSun2Lki3RfnvK7LeA_b6dwbUkgkrZYNn8l7utaSEgWfao=\" rel=\"nofollow noopener\" target=\"_blank\">Juan Monteverde<\/a>, founder and managing partner of the class action firm <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=wsufgIZYSe95JPJqSWa5ySlpm2KzLKRQIwTOA8WriW9kOjFE6LMrW1z5UFwIMjNZS__SNZaWIBa5Jj1qa_W7duKvc3PFYM6pREI58QS3H1g=\" rel=\"nofollow noopener\" target=\"_blank\">Monteverde &amp; Associates PC<\/a> (the \u201cM&amp;A Class Action Firm\u201d), a national securities firm rated\u00a0<strong>Top 50\u00a0<\/strong>in the 2018-2021 ISS Securities Class Action Services Report and headquartered at the\u00a0<strong>Empire State Building<\/strong>\u00a0in New York City, is investigating:<\/p>\n<ul type=\"disc\">\n<li>\n          <strong>Horizon Therapeutics Public Limited Co. (NASDAQ: <\/strong><br \/>\n          <a href=\"https:\/\/finance.yahoo.com\/quote\/HZNP\" rel=\"nofollow noopener\" target=\"_blank\"><br \/>\n            <strong>HZNP<\/strong><br \/>\n          <\/a><br \/>\n          <strong>), <\/strong>relating to its proposed acquisition by Amgen, Inc. Under the terms of the agreement, HZNP shareholders will receive $116.50 in cash per share they own. <strong>Click here for more information: <\/strong><a href=\"https:\/\/www.monteverdelaw.com\/case\/horizon-therapeutics-public-limited-co\" rel=\"nofollow noopener\" target=\"_blank\"><strong>https:\/\/www.monteverdelaw.com\/case\/horizon-therapeutics-public-limited-co<\/strong><\/a><strong>. It is free and there is no cost or obligation to you.<\/strong><\/li>\n<\/ul>\n<ul type=\"disc\">\n<li>\n          <strong>Angion Biomedica Corp. (NASDAQ: <\/strong><br \/>\n          <a href=\"https:\/\/finance.yahoo.com\/quote\/ANGN\" rel=\"nofollow noopener\" target=\"_blank\"><br \/>\n            <strong>ANGN<\/strong><br \/>\n          <\/a><br \/>\n          <strong>)<\/strong>, relating to its proposed merger with Elicio Therapeutics. Under the terms of the agreement, Elicio shareholders are expected to receive new shares of ANGN, with ANGN shareholders expected to own approximately 34.5% of the combined company. <strong>Click here for more information: <\/strong><a href=\"https:\/\/www.monteverdelaw.com\/case\/angion-biomedia-corp\" rel=\"nofollow noopener\" target=\"_blank\"><strong>https:\/\/www.monteverdelaw.com\/case\/angion-biomedia-corp<\/strong><\/a><strong>. It is free and there is no cost or obligation to you.<\/strong><\/li>\n<\/ul>\n<ul type=\"disc\">\n<li>\n          <strong>Trean Insurance Group, Inc. (NASDAQ: <\/strong><br \/>\n          <a href=\"https:\/\/finance.yahoo.com\/quote\/TIG\" rel=\"nofollow noopener\" target=\"_blank\"><br \/>\n            <strong>TIG<\/strong><br \/>\n          <\/a><br \/>\n          <strong>)<\/strong>, relating to its proposed acquisition by affiliates of Altaris, LLC. Under the terms of the agreement, TIG shareholders are expected to receive $6.15 in cash per share they own. <strong>Click here for more information: <\/strong><a href=\"https:\/\/www.monteverdelaw.com\/case\/trean-insurance-group-inc\" rel=\"nofollow noopener\" target=\"_blank\"><strong>https:\/\/www.monteverdelaw.com\/case\/trean-insurance-group-inc<\/strong><\/a><strong>. It is free and there is no cost or obligation to you.<\/strong><\/li>\n<\/ul>\n<ul type=\"disc\">\n<li>\n          <strong>Concert Pharmaceuticals, Inc. (NASDAQ: <\/strong><br \/>\n          <a href=\"https:\/\/finance.yahoo.com\/quote\/CNCE\" rel=\"nofollow noopener\" target=\"_blank\"><br \/>\n            <strong>CNCE<\/strong><br \/>\n          <\/a><br \/>\n          <strong>)<\/strong>, relating to its proposed acquisition by Sun Pharmaceutical Industries Limited. Under the terms of the tender offer, CNCE shareholders are expected to receive $8.00 in cash and one non-tradeable CVR worth a deferred $3.50 in cash per share they own. <strong>Click here for more information: <\/strong><a href=\"https:\/\/www.monteverdelaw.com\/case\/concert-pharmaceuticals-inc\" rel=\"nofollow noopener\" target=\"_blank\"><strong>https:\/\/www.monteverdelaw.com\/case\/concert-pharmaceuticals-inc<\/strong><\/a><strong>. It is free and there is no cost or obligation to you.<\/strong><\/li>\n<\/ul>\n<p>\n        <strong>About Monteverde &amp; Associates PC<\/strong>\n      <\/p>\n<p>We are a national class action securities litigation law firm that has recovered millions of dollars and is committed to protecting shareholders from corporate wrongdoing. We were listed in the\u00a0<strong>Top 50\u00a0<\/strong>in the 2018-2021 ISS Securities Class Action Services Report. Our lawyers have significant experience litigating Mergers &amp; Acquisitions and Securities Class Actions. Mr. Monteverde is recognized by Super Lawyers in 2013 and 2017-2019 as a\u00a0Rising Star and in 2022 as a Super Lawyer in Securities Litigation. He has also been selected by Martindale-Hubbell as a 2017-2021 Top Rated Lawyer. Our firm&#8217;s recent successes include changing the law in a significant victory that lowered the standard of liability under Section 14(e) of the Exchange Act in the Ninth Circuit. Thereafter, our firm successfully preserved this victory by obtaining dismissal of a writ of certiorari as improvidently granted at the United States Supreme Court.<em>\u00a0Emulex Corp. v. Varjabedian<\/em>, 139 S. Ct. 1407 (2019). Also, we have recovered or secured over a dozen cash common funds for shareholders in mergers &amp; acquisitions class action cases.<\/p>\n<p>If you own common stock in any of the above listed companies and wish to obtain additional information and protect your investments free of charge, please visit our <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=4R_ZKqbBUteLVRbS_LbrpKg9eSoLTO17j4D6ZeNFvtGiONmzkYKwH_4kVLb8qoe9p_aLq5kOXwm5UUr1Re7j3BNHGsCYKsTiDciEWjBihpYfqnZ4uMEeDcUIbL0twfI32P1HOynq8vw4u67XPxF_B0Dbk114jKsdMh27cPitxlVPgXqiPh6qB31nD_DUYN5h\" rel=\"nofollow noopener\" target=\"_blank\"><strong><u>website<\/u><\/strong><\/a> or contact Juan E. Monteverde, Esq. either via e-mail at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=JOH5-_GMzwOxXsEuXRgOmV1SLMjrGDaM6f_HacaZQ_lA3jdA2CdSTOY5uxFdMlgEByaMfuh0uHQOlc4ndcmcgUI1XZaPm5HENLfOSi64Wx0Oemkeq8eW4cBS3SIAaFhZ\" rel=\"nofollow noopener\" target=\"_blank\"><strong><u>jmonteverde@monteverdelaw.com<\/u><\/strong><\/a> or by telephone at (212) 971-1341.<\/p>\n<p>Contact:<br \/>Juan E. Monteverde, Esq.<br \/>MONTEVERDE &amp; ASSOCIATES PC<br \/><strong>The Empire State Building<\/strong><br \/>350 Fifth Ave. Suite 4405<br \/>New York, NY 10118<br \/>United States of America<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=JOH5-_GMzwOxXsEuXRgOmV1SLMjrGDaM6f_HacaZQ_kSlNtQAFJVhqKAodrnw6eu5IS3E5Eo_JRQe_GKwB_xrFcL9j1tCALbishhsDb2YGiPJNoE6IlrOqyJHs59bvo8\" rel=\"nofollow noopener\" target=\"_blank\"><u>jmonteverde@monteverdelaw.com<\/u><\/a><br \/>Tel: (212) 971-1341<\/p>\n<p>Attorney Advertising. (C) 2023 Monteverde &amp; Associates PC.\u00a0The law firm responsible for this advertisement is Monteverde &amp; Associates PC (<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=9NTa1Zlm9sFgnmzWxo4L3WnBLaqhEanvSPysdALw5QEwMwQIHIZ7GOy8sKR6x_-R6LqoP9I-ObzQiJuBS6tspP85SqF_nwAPyZxZfTnxGaAgqnvGQZKzBWmSU7v-_F4JvT1OrBJvSKottextxvKGjm49nvCyaGfG8yNXpJ36QdJUR2E_uQlwPQNn895tsJymW3lXhal2c8th2Ix9ETlWK2h9WSkxVigVDohLVkw7J78=\" rel=\"nofollow noopener\" target=\"_blank\"><u>www.monteverdelaw.com<\/u><\/a>). Prior results do not guarantee a similar outcome with respect to any future matter.<\/p>\n<\/p>\n<p>      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODczNjc4NCM1Mzc1MTgyIzIxODQzNTk=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/ZjkzMWQwYmEtMDg2Mi00ZjIwLTgyYmEtMWZjNzAxOGU0ZDViLTExOTU5MTM=\/tiny\/Monteverde-Associates-PC.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>NEW YORK, Jan. 25, 2023 (GLOBE NEWSWIRE) &#8212; Juan Monteverde, founder and managing partner of the class action firm Monteverde &amp; Associates PC (the \u201cM&amp;A Class Action Firm\u201d), a national securities firm rated\u00a0Top 50\u00a0in the 2018-2021 ISS Securities Class Action Services Report and headquartered at the\u00a0Empire State Building\u00a0in New York City, is investigating: Horizon Therapeutics Public Limited Co. (NASDAQ: HZNP ), relating to its proposed acquisition by Amgen, Inc. Under the terms of the agreement, HZNP shareholders will receive $116.50 in cash per share they own. Click here for more information: https:\/\/www.monteverdelaw.com\/case\/horizon-therapeutics-public-limited-co. It is free and there is no cost or obligation to you. Angion Biomedica Corp. (NASDAQ: ANGN ), relating to its proposed merger with Elicio Therapeutics. Under the &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/alert-the-ma-class-action-firm-continues-investigating-the-merger-hznp-angn-tig-cnce\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;ALERT: The M&amp;A Class Action Firm Continues Investigating the Merger \u2013 HZNP, ANGN, TIG, CNCE&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-725823","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>ALERT: The M&amp;A Class Action Firm Continues Investigating the Merger \u2013 HZNP, ANGN, TIG, CNCE - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/alert-the-ma-class-action-firm-continues-investigating-the-merger-hznp-angn-tig-cnce\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ALERT: The M&amp;A Class Action Firm Continues Investigating the Merger \u2013 HZNP, ANGN, TIG, CNCE - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"NEW YORK, Jan. 25, 2023 (GLOBE NEWSWIRE) &#8212; Juan Monteverde, founder and managing partner of the class action firm Monteverde &amp; Associates PC (the \u201cM&amp;A Class Action Firm\u201d), a national securities firm rated\u00a0Top 50\u00a0in the 2018-2021 ISS Securities Class Action Services Report and headquartered at the\u00a0Empire State Building\u00a0in New York City, is investigating: Horizon Therapeutics Public Limited Co. (NASDAQ: HZNP ), relating to its proposed acquisition by Amgen, Inc. Under the terms of the agreement, HZNP shareholders will receive $116.50 in cash per share they own. Click here for more information: https:\/\/www.monteverdelaw.com\/case\/horizon-therapeutics-public-limited-co. It is free and there is no cost or obligation to you. Angion Biomedica Corp. (NASDAQ: ANGN ), relating to its proposed merger with Elicio Therapeutics. Under the &hellip; Continue reading &quot;ALERT: The M&amp;A Class Action Firm Continues Investigating the Merger \u2013 HZNP, ANGN, TIG, CNCE&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/alert-the-ma-class-action-firm-continues-investigating-the-merger-hznp-angn-tig-cnce\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-01-25T21:03:44+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODczNjc4NCM1Mzc1MTgyIzIxODQzNTk=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alert-the-ma-class-action-firm-continues-investigating-the-merger-hznp-angn-tig-cnce\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alert-the-ma-class-action-firm-continues-investigating-the-merger-hznp-angn-tig-cnce\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"ALERT: The M&amp;A Class Action Firm Continues Investigating the Merger \u2013 HZNP, ANGN, TIG, CNCE\",\"datePublished\":\"2023-01-25T21:03:44+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alert-the-ma-class-action-firm-continues-investigating-the-merger-hznp-angn-tig-cnce\\\/\"},\"wordCount\":597,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alert-the-ma-class-action-firm-continues-investigating-the-merger-hznp-angn-tig-cnce\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODczNjc4NCM1Mzc1MTgyIzIxODQzNTk=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alert-the-ma-class-action-firm-continues-investigating-the-merger-hznp-angn-tig-cnce\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alert-the-ma-class-action-firm-continues-investigating-the-merger-hznp-angn-tig-cnce\\\/\",\"name\":\"ALERT: The M&amp;A Class Action Firm Continues Investigating the Merger \u2013 HZNP, ANGN, TIG, CNCE - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alert-the-ma-class-action-firm-continues-investigating-the-merger-hznp-angn-tig-cnce\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alert-the-ma-class-action-firm-continues-investigating-the-merger-hznp-angn-tig-cnce\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODczNjc4NCM1Mzc1MTgyIzIxODQzNTk=\",\"datePublished\":\"2023-01-25T21:03:44+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alert-the-ma-class-action-firm-continues-investigating-the-merger-hznp-angn-tig-cnce\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alert-the-ma-class-action-firm-continues-investigating-the-merger-hznp-angn-tig-cnce\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alert-the-ma-class-action-firm-continues-investigating-the-merger-hznp-angn-tig-cnce\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODczNjc4NCM1Mzc1MTgyIzIxODQzNTk=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODczNjc4NCM1Mzc1MTgyIzIxODQzNTk=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alert-the-ma-class-action-firm-continues-investigating-the-merger-hznp-angn-tig-cnce\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ALERT: The M&amp;A Class Action Firm Continues Investigating the Merger \u2013 HZNP, ANGN, TIG, CNCE\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ALERT: The M&amp;A Class Action Firm Continues Investigating the Merger \u2013 HZNP, ANGN, TIG, CNCE - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/alert-the-ma-class-action-firm-continues-investigating-the-merger-hznp-angn-tig-cnce\/","og_locale":"en_US","og_type":"article","og_title":"ALERT: The M&amp;A Class Action Firm Continues Investigating the Merger \u2013 HZNP, ANGN, TIG, CNCE - Market Newsdesk","og_description":"NEW YORK, Jan. 25, 2023 (GLOBE NEWSWIRE) &#8212; Juan Monteverde, founder and managing partner of the class action firm Monteverde &amp; Associates PC (the \u201cM&amp;A Class Action Firm\u201d), a national securities firm rated\u00a0Top 50\u00a0in the 2018-2021 ISS Securities Class Action Services Report and headquartered at the\u00a0Empire State Building\u00a0in New York City, is investigating: Horizon Therapeutics Public Limited Co. (NASDAQ: HZNP ), relating to its proposed acquisition by Amgen, Inc. Under the terms of the agreement, HZNP shareholders will receive $116.50 in cash per share they own. Click here for more information: https:\/\/www.monteverdelaw.com\/case\/horizon-therapeutics-public-limited-co. It is free and there is no cost or obligation to you. Angion Biomedica Corp. (NASDAQ: ANGN ), relating to its proposed merger with Elicio Therapeutics. Under the &hellip; Continue reading \"ALERT: The M&amp;A Class Action Firm Continues Investigating the Merger \u2013 HZNP, ANGN, TIG, CNCE\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/alert-the-ma-class-action-firm-continues-investigating-the-merger-hznp-angn-tig-cnce\/","og_site_name":"Market Newsdesk","article_published_time":"2023-01-25T21:03:44+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODczNjc4NCM1Mzc1MTgyIzIxODQzNTk=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alert-the-ma-class-action-firm-continues-investigating-the-merger-hznp-angn-tig-cnce\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alert-the-ma-class-action-firm-continues-investigating-the-merger-hznp-angn-tig-cnce\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"ALERT: The M&amp;A Class Action Firm Continues Investigating the Merger \u2013 HZNP, ANGN, TIG, CNCE","datePublished":"2023-01-25T21:03:44+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alert-the-ma-class-action-firm-continues-investigating-the-merger-hznp-angn-tig-cnce\/"},"wordCount":597,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alert-the-ma-class-action-firm-continues-investigating-the-merger-hznp-angn-tig-cnce\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODczNjc4NCM1Mzc1MTgyIzIxODQzNTk=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alert-the-ma-class-action-firm-continues-investigating-the-merger-hznp-angn-tig-cnce\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/alert-the-ma-class-action-firm-continues-investigating-the-merger-hznp-angn-tig-cnce\/","name":"ALERT: The M&amp;A Class Action Firm Continues Investigating the Merger \u2013 HZNP, ANGN, TIG, CNCE - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alert-the-ma-class-action-firm-continues-investigating-the-merger-hznp-angn-tig-cnce\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alert-the-ma-class-action-firm-continues-investigating-the-merger-hznp-angn-tig-cnce\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODczNjc4NCM1Mzc1MTgyIzIxODQzNTk=","datePublished":"2023-01-25T21:03:44+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alert-the-ma-class-action-firm-continues-investigating-the-merger-hznp-angn-tig-cnce\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/alert-the-ma-class-action-firm-continues-investigating-the-merger-hznp-angn-tig-cnce\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alert-the-ma-class-action-firm-continues-investigating-the-merger-hznp-angn-tig-cnce\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODczNjc4NCM1Mzc1MTgyIzIxODQzNTk=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODczNjc4NCM1Mzc1MTgyIzIxODQzNTk="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alert-the-ma-class-action-firm-continues-investigating-the-merger-hznp-angn-tig-cnce\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"ALERT: The M&amp;A Class Action Firm Continues Investigating the Merger \u2013 HZNP, ANGN, TIG, CNCE"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/725823","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=725823"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/725823\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=725823"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=725823"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=725823"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}